Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
PEPTAZOL 30/MG EC CAP 28/CAP
- Sku : I-005075
Key features
Peptazole 30mg Capsule 28 Capsules (PEPTAZOLE) is an enteric‑coated capsule formulation containing lansoprazole 30 mg as the active ingredient. As a proton pump inhibitor, it reduces gastric acid secretion by inhibiting the H+/K+ ATPase (proton pump) in gastric parietal cells. It is indicated for duodenal and gastric ulcers, NSAID-associated gastric and duodenal ulcers, gastroesophageal reflux disease (GERD) and erosive esophagitis, Helicobacter pylori eradication in combination therapy, and Zollinger‑Ellison syndrome. Available by prescription as enteric‑coated capsules in a pack of 28 capsules.- Brand: PEPTAZOLE
- Active Ingredient: LANSOPRAZOLE 30mg
- Strength: 30mg
- Dosage Form: Capsule
- Pack Size: 28 Capsules
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Proton Pump Inhibitors
- Drug Class: Proton Pump Inhibitor (PPI)
- Manufacturer: SPIMACO
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1005222007
- Shelf Life: 36 months
- Storage: store below 30°c
- Gi Condition: Acid Reflux/GERD, Ulcer
Frequently bought together
Indications
Approved Uses
Duodenal ulcer, gastric ulcer, NSAID-associated gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), erosive esophagitis, Helicobacter pylori eradication (in combination therapy), Zollinger-Ellison syndrome
Dosage & Administration
Dosing by Condition
GERD: 15-30mg once daily for 4-8 weeks; Erosive esophagitis: 30mg once daily for up to 8 weeks; Duodenal ulcer: 15mg once daily for 4 weeks; Gastric ulcer: 30mg once daily for 4-8 weeks; H. pylori eradication: 30mg twice daily for 10-14 days (in combination); Zollinger-Ellison syndrome: 60mg once daily, titrate as needed; NSAID-associated ulcer: 30mg once daily for 4-8 weeks
Initial Dose
30mg once daily before breakfast
Maintenance Dose
15-30mg once daily
Maximum Dose
120mg/day (Zollinger-Ellison syndrome); 30mg/day for standard indications
Children's Dosage
Children 1-11 years (≤30kg): 15mg once daily; Children 1-11 years (>30kg): 30mg once daily; Children 12-17 years: 15-30mg once daily. Not approved under 1 year of age
How to Take
Swallow capsule whole before eating. Do not crush or chew. If swallowing is difficult, capsule may be opened and granules sprinkled on soft food (e.g., applesauce) or mixed in apple juice - swallow immediately without chewing
Side Effects
Common Side Effects
Headache, diarrhea, nausea, abdominal pain, constipation, flatulence, dizziness
Side Effect Frequency
Very common (>10%): headache. Common (1-10%): diarrhea, nausea, abdominal pain, constipation, flatulence, dizziness, rash. Uncommon (<1%): hypomagnesemia (with prolonged use), acute interstitial nephritis, Stevens-Johnson syndrome, Clostridioides difficile-associated diarrhea, bone fractures
Safety & Warnings
Contraindications
Hypersensitivity to lansoprazole or any benzimidazole PPI, concurrent use with rilpivirine-containing products
Warnings & Precautions
Long-term use (>1 year) associated with hypomagnesemia, vitamin B12 deficiency, and increased fracture risk. May mask symptoms of gastric malignancy - exclude malignancy before initiating therapy. Risk of Clostridioides difficile-associated diarrhea. Acute interstitial nephritis reported. Use with caution in severe hepatic impairment. Concomitant use with clopidogrel may reduce antiplatelet effect
Age Restriction
Not approved under 1 year of age
Driving Warning
Safe
Drug Interactions
Drug Interactions
Clopidogrel (reduced antiplatelet effect via CYP2C19 inhibition), methotrexate (increased methotrexate levels), atazanavir/nelfinavir (reduced absorption), rilpivirine (reduced efficacy), warfarin (increased INR), digoxin (increased digoxin levels), ketoconazole/itraconazole (reduced antifungal absorption), sucralfate (delayed lansoprazole absorption), tacrolimus (increased tacrolimus levels)
Food Interaction
Take 30-60 minutes before meals (on empty stomach) for optimal efficacy. Food reduces bioavailability if taken with or after meals
Special Populations
Breastfeeding
Caution
Children
Children 1-11 years (≤30kg): 15mg once daily; Children 1-11 years (>30kg): 30mg once daily; Children 12-17 years: 15-30mg once daily. Not approved under 1 year of age
Elderly
Standard adult dosing. Dose reduction not routinely required; however, use the lowest effective dose for the shortest duration necessary
Kidney Impairment
No adjustment needed
Liver Impairment
Mild-moderate impairment: no adjustment needed. Severe impairment (Child-Pugh C): reduce dose to maximum 15mg/day
Storage & Patient Advice
Missed Dose
Take as soon as remembered. If it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose
Overdose
Symptoms: nausea, vomiting, dizziness, abdominal pain, diarrhea, flushing, headache, tachycardia. No specific antidote. Treatment: supportive care, gastric lavage if indicated. Lansoprazole is not significantly removed by hemodialysis. Seek immediate medical attention
Patient Counseling
Take this capsule 30-60 minutes before your first meal of the day for best effect. Swallow the capsule whole - do not crush or chew. If you have difficulty swallowing, you may open the capsule and sprinkle the granules on soft food or in apple juice, but swallow immediately without chewing. Do not take antacids within 1 hour of this medication unless directed. Report any persistent diarrhea, muscle cramps, irregular heartbeat, or signs of kidney problems (decreased urination, swelling). If you are taking clopidogrel (blood thinner), inform your doctor as lansoprazole may reduce its effectiveness. Long-term use requires periodic monitoring of magnesium levels. Do not stop taking this medication without consulting your doctor if prescribed for ulcer healing or H. pylori eradication
Pharmacology
Half-Life
1-2 hours
Bioavailability
80-85% (enteric-coated formulation)
Metabolism
Hepatic via CYP2C19 (primary) and CYP3A4
Product Information
Available Dosage Forms
Enteric-coated capsule, orally disintegrating tablet, oral suspension
Composition per Dose
Each enteric-coated capsule: 30mg lansoprazole
Generic Availability
Yes
Gi Condition
Acid Reflux/GERD, Ulcer
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)















